Nova Eye Medical Limited / Fundamentals
Income statement
- Net revenue
€25.14M - Cost of goods sold
€12.50M - Gross profit
€12.64M - SG&A expenses
€18.27M - R&D expenses
€1.34M - EBITDA
-€7.99M - D&A
€2.45M - EBIT
-€7.72M - Interest expenses
€53.22K - EBT
-€13.53M - Tax expenses
-€717.01K - Net income
-€12.81M
Cash flow statement
- Net deferred tax
-€1.22M - Non-cash items
€6.19M - Changes in working capital
-€1.19M - Operating cash flow
-€7.60M - Capex
€416.76K - Other investing cash flow
-€177.01K - Net investing cash flow
-€483.98K - Total cash dividends paid
€0.00 - Issuance of common stock
€8.35M - Debt repayment
-€384.27K - Other financing cash flow
€8.04M - Net financing cash flow
€7.65M - Foreign exchange effects
€4.31M - Net change in cash
€3.23M - Cash at end of period
€1.26M - Free cash flow
-€7.19M
Balance sheet
- Cash and cash equivalents
€1.26M - Cash and short-term investments
€1.26M - Total receivables
€1.73M - Inventory
€2.44M - Other current assets
€175.33K - Total current assets
€5.61M - Property, plant & equipment
€2.08M - Goodwill
€0.00 - Intangible assets
€4.20M - Long-term investments
€0.00 - Other non-current assets
€2.48M - Total non-current assets
€8.76M - Total assets
€14.37M - Accounts payable
€1.60M - Short-term debt
€305.85K - Other current liabilities
€1.15M - Total current liabilities
€3.06M - Long-term debt
€1.59M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€0.00 - Total non-current liabilities
€1.59M - Total liabilities
€4.64M - Common stock
€29.54M - Retained earnings
-€20.21M - Other equity
€405.00K - Total equity
€9.73M - Total liabilities and shareholders' equity
€14.37M
Company information
- Market capitalization
€17.51M - Employees
301 - Enterprise Value
€35.22M
Company ratios
- Gross margin
-
50.3% Much better than peer group: -1,328.7% - EBITDA margin
-
-31.8% Much better than peer group: -745,385.1% - EBIT margin
-
-30.7% Much better than peer group: -834,491.7% - EBT margin
-
-53.8% Much better than peer group: -860,304.0% - Net margin
-
-51.0% Much better than peer group: -860,305.3% - ROE
-
-131.6% Much better than peer group: -7,722.2% - ROA
-
-89.1% Much better than peer group: -4,801.7% - Asset turnover
-
174.9% Much worse than peer group: 237.2% - FCF margin
-
-31.9% Much better than peer group: -1,131,692.9% - FCF yield
-45.8% - Efficiency ratio
131.8% - Net sales per employee
-
€83.53K - Net income per employee
-
-€42.56K